International Brand Name:
In treatment of:
Treatment of allergic condition
Sleepiness Weakness Fatigue Dry mouth Pharyngitis Dyspepsia Increase in appetite Rhinitis
Contraindicated in patients with hypersensitivity to Rupatadine or any of the excipients.
Renal insufficiency Hepatic insufficiency
Co-administration of 20 mg Rupatadine with the known CYP3A4 inhibitors Ketoconazole (200 mg,once daily) Ketoconazole inhibits both the presystemic and systemic metabolism of Rupatadine, increasing about 10-fold the exposure of unchanged drug and decreasing the exposure of metabolites.
Oral- Adult and children (>12yrs) -10mg once daily.